4.6 Article

Level of renal function in patients starting dialysis: an ERA-EDTA Registry study

Journal

NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 25, Issue 10, Pages 3315-3325

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfq209

Keywords

dialysis start; end-stage renal disease; epidemiology; glomerular filtration rate; serum creatinine

Funding

  1. European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)

Ask authors/readers for more resources

Methods. Renal registries participating in the European Renal Association-European Dialysis and Transplant Association Registry provided data on serum creatinine 0-4 weeks before the start of dialysis in incident dialysis patients in 1999 and 2003. Data were available in 11 472 patients from nine renal registries. Glomerular filtration rate (GFR) was estimated by the four-variable Modification of Diet in Renal Disease equation. Results. The unadjusted median eGFR at the start of dialysis was 7.0 mL/min/1.73 m(2) in the 1999 data (median serum creatinine 7.5 mg/dL) and 7.7 mL/min/1.73 m(2) in the 2003 data (serum creatinine 7.0 mg/dL). Using linear regression with adjustment for the other covariates, older patients, males, patients with diabetes mellitus, hypertension/renal vascular disease (HT/RVD) as primary renal disease (vs glomerulonephritis), ischaemic heart disease or peripheral vascular disease and patients starting on peritoneal dialysis (PD) initiated dialysis at higher levels of eGFR (range delta eGFR: 0.1-1.2 mL/min/1.73 m(2)). Using the same analyses, eGFR differed between countries (range: 6.5-8.6 mL/min/1.73 m(2)). Conclusions. During 2003, patients started dialysis at somewhat higher eGFR levels than those starting during 1999. There were also international differences in eGFR. Such differences may, at least in part, be explained by differences in creatinine measurement methods between countries and time periods. Finally, older patients, males, patients with HT/RVD or comorbidity and those starting on PD had slightly higher eGFR levels than younger patients, females, those with glomerulonephritis, without comorbidity and those starting on haemodialysis. Further research is needed into other, more clinically related factors affecting the decision to start dialysis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Transplantation

European nephrologists' views on remote patient management for end-stage kidney disease

Rianne W. de Jong, Kitty J. Jager, Tom H. F. Broens, Vianda S. Stel

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Editorial Material Transplantation

A snapshot of European registries on chronic kidney disease patients not on kidney replacement therapy

Kitty J. Jager, Anders Asberg, Frederic Collart, Cecile Couchoud, Marie Evans, Patrik Finne, Ileana Peride, Ivan Rychlik, Ziad A. Massy

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Article Urology & Nephrology

Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients with Systemic Lupus Erythematosus: Findings From the ERA Registry

Ondrej Derner, Anneke Kramer, Zdenka Hruskova, Mustafa Arici, Frederic Collart, Patrik Finne, Laura Fuentes Sanchez, Jerome Harambat, Marc H. Hemmelder, Kristine Hommel, Julia Kerschbaum, Johan De Meester, Runolfur Palsson, Marten Segelmark, Rannveig Skrunes, Jamie P. Traynor, Oscar Zurriaga, Ziad A. Massy, Kitty J. Jager, Vianda S. Stel, Vladimir Tesar

Summary: The incidence and prevalence of kidney replacement therapy (KRT) for kidney failure due to systemic lupus erythematosus (SLE) remained stable during the study period. The survival of SLE patients receiving KRT was similar to those with other diseases, but was worse after kidney transplant. Infections were a common cause of death in SLE patients receiving KRT.

AMERICAN JOURNAL OF KIDNEY DISEASES (2022)

Article Oncology

Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study)

Marta Hernandez-Garcia, Ana Molina-Barcelo, Mercedes Vanaclocha-Espi, Oscar Zurriaga, Beatriz Perez-Gomez, Nuria Aragones, Pilar Amiano, Jone M. Altzibar, Gemma Castano-Vinyals, Maria Sala, Maria Ederra, Vicente Martin, Ines Gomez-Acebo, Carmen Vidal, Adonina Tardon, Rafael Marcos-Gragera, Marina Pollan, Manolis Kogevinas, Dolores Salas

Summary: There are differences in breast cancer-risk factor associations according to detection method and tumor phenotype among Spanish women aged 50-69. Reproductive risk factors are associated with screen-detected BC, as are HR+ tumors. Differences in BC-risk factor associations may be related to prevailing phenotypes among categories.

CANCER CAUSES & CONTROL (2022)

Article Public, Environmental & Occupational Health

Clarity and consistency in stillbirth reporting in Europe: why is it so hard to get this right?

Mika Gissler, Melanie Durox, Lucy Smith, Beatrice Blondel, Lisa Broeders, Ashna Hindori-Mohangoo, Karen Kearns, Rumyana Kolarova, Marzia Loghi, Urelija Rodin, Katarzyna Szamotulska, Petr Velebil, Guy Weber, Oscar Zurriaga, Jennifer Zeitlin

Summary: Routine stillbirth data in European countries are not comparable and should not be used for benchmarking or surveillance without careful verification. Recommendations for improvement include using gestational age as a cut-off, excluding late terminations of pregnancy, and linking multiple sources to improve the quality of national databases.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2022)

Letter Urology & Nephrology

Confirmed Drop in Treatment of Patients with Incident End-Stage Kidney Disease During the Novel Coronavirus Disease 2019 Pandemic

Lucas Jacobs, Arnaud Devresse, Thomas Baudoux, Frederic Collart

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Transplantation

Work status and work ability of patients receiving kidney replacement therapy: results from a European survey

Rianne W. de Jong, Edwin J. Boezeman, Nicholas C. Chesnaye, Frederike J. Bemelman, Ziad A. Massy, Kitty J. Jager, Vianda S. Stel, Angela G. E. M. de Boer

Summary: Low employment rates and impaired work ability were prevalent among European patients receiving kidney replacement therapy. Employment was associated with demographic, disease-related, work-related, and macro-economic factors.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Article Urology & Nephrology

The ERA Registry Annual Report 2019: summary and age comparisons

Rianne Boenink, Megan E. Astley, Jilske A. Huijben, Vianda S. Stel, Julia Kerschbaum, Mai Ots-Rosenberg, Anders A. Asberg, Frantisek Lopot, Eliezer Golan, Pablo Castro de la Nuez, Marta Rodriguez Camblor, Sara Trujillo-Aleman, Juan Carlos Ruiz San Millan, Pablo Ucio Mingo, Juan Manuel Diaz, M. Encarnacion Bouzas-Caamano, Marta Artamendi, Manuel Aparicio Madre, Carmen Santiuste de Pablos, Maria Fernanda Slon Roblero, Oscar Zurriaga, Maria E. Stendahl, Samira Bell, Alma Idrizi, Kyriakos Ioannou, Alicja Debska-Slizien, Ana A. Galvao, Johan M. De Meester, Halima Resic, Kristine Hommel, Danilo Radunovic, Runolfur Palsson, Mathilde Lassalle, Patrik Finne, Maria De los Angeles-Garcia Bazaga, Nikola Gjorgjievski, Nurhan Seyahi, Marjolein Bonthuis, Alberto Ortiz, Kitty J. Jager, Anneke Kramer

Summary: This study collected data on renal replacement therapy (RRT) for end-stage renal disease from European and Mediterranean countries. It analyzed the incidence and prevalence of RRT, kidney transplantation activity, and survival probabilities. The study also compared different age categories and found significant differences.

CLINICAL KIDNEY JOURNAL (2022)

Article Transplantation

Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study

Jilske A. Huijben, Anneke Kramer, Julia Kerschbaum, Johan de Meester, Frederic Collart, Olga Lucia Rodriguez Arevalo, Jaakko Helve, Mathilde Lassalle, Runolfur Palsson, Marc ten Dam, Anna Casula, Shona Methven, Alberto Ortiz, Pietro Manuel Ferraro, Marten Segelmark, Pablo Ucio Mingo, Mustafa Arici, Anna Varberg Reisaeter, Maria Stendahl, Vianda S. Stel, Kitty J. Jager

Summary: This study describes the trends in incidence, prevalence, and survival of patients on kidney replacement therapy (KRT) for end-stage kidney disease (ESKD) in Europe from 2008 to 2017. The incidence of KRT remained stable initially but increased slightly in recent years, primarily driven by an increase in older male patients. Diabetes mellitus was found to be a leading cause of kidney failure. The prevalence of KRT increased over the study period, and patient survival on KRT improved.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Multidisciplinary Sciences

Hospital length of stay among children with and without congenital anomalies across 11 European regions-A population-based data linkage study

Stine Kjaer Urhoj, Joachim Tan, Joan K. Morris, Joanne Given, Gianni Astolfi, Silvia Baldacci, Ingeborg Barisic, Joanna Brigden, Clara Cavero-Carbonell, Hannah Evans, Mika Gissler, Anna Heino, Sue Jordan, Renee Lutke, Ljubica Odak, Aurora Puccini, Michele Santoro, Ieuan Scanlon, Hermien E. K. de Walle, Diana Wellesley, Oscar Zurriaga, Maria Loane, Ester Garne

Summary: Children with congenital anomalies have a higher risk of hospitalization and longer length of stay. However, the outlook improves after the first year. It is important to provide support and assistance to the parents of children with congenital anomalies, informing them about the necessary care and the impact on family life and siblings.

PLOS ONE (2022)

Article Health Care Sciences & Services

Diagnostic delay in rare diseases: between fear and resilience

Lucia Paramo-Rodriguez, Clara Cavero-Carbonell, Sandra Guardiola-Vilarroig, Aurora Lopez-Maside, M. Eugenia Gonzalez Sanjuan, Oscar Zurriaga

Summary: This study used a qualitative approach to investigate the impact of diagnosis delay in rare diseases and explore the psychosocial needs of patients. The findings indicated that individuals with rare diseases exhibited high resilience and coping capacity, emphasizing the importance of professional psychosocial support during the diagnostic process.

GACETA SANITARIA (2023)

Article Obstetrics & Gynecology

Trends in caesarean section rates in Europe from 2015 to 2019 using Robson's Ten Group Classification System: A Euro-Peristat study

Melissa Amyx, Marianne Philibert, Alex Farr, Serena Donati, Alexander K. Smarason, Vlad Tica, Petr Velebil, Sophie Alexander, Melanie Durox, Maria Fernandez Elorriaga, Guenther Heller, Theopisti Kyprianou, Ewa Mierzejewska, Ivan Verdenik, Irisa Zile-Velika, Jennifer Zeitlin

Summary: The study assessed changes in caesarean section (CS) rates in Europe from 2015 to 2019, and used the Robson Ten Group Classification System (TGCS) to evaluate the contribution of different obstetric populations to overall CS rates and trends. The findings showed that CS rates and trends varied among the 28 European countries. The TGCS analysis revealed that labour induction increased in most countries, while multiple pregnancies decreased. Countries with decreasing CS rates tended to see decreases across all TGCS groups, whereas countries with increasing rates tended to see increases in most groups. In countries with the greatest increase in CS rates, the absolute contribution of certain TGCS groups to the overall CS rate tended to increase.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Article Transplantation

Prescribing the dialysis dose and treatment frequency in home haemodialysis

Francesco Gaetano Casino, Maria Fernanda Slon Roblero, Silvia Gonzalez-Sanchidrian, Sandra Gallego Dominguez, Ignacio Lorenzo Ferris, Valerie A. Luyckx, Vassilios Liakopoulos, Sandip Mitra, Javier Deira Lorenzo, Carlo Basile

Summary: The aim of this study was to obtain a new formula for stdKt/V that defines the minimum required values of eKt/V and TF to achieve the targeted stdKtV in home haemodialysis. The results showed that the formula is reliable and can support clinicians in prescribing the dialysis dose and treatment frequency for patients undergoing HHD.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Genetics & Heredity

ORPHAcodes use for the coding of rare diseases: comparison of the accuracy and cross country comparability

Monica Mazzucato, Laura Visona Dalla Pozza, Paola Facchin, Celine Angin, Francis Agius, Clara Cavero-Carbonell, Virginia Corrochano, Katerina Hanusova, Kurt Kirch, Deborah Lambert, Caterina Lucano, Sylvie Maiella, Monica Panzaru, Cristina Rusu, Stefanie Weber, Oscar Zurriaga, Miroslav Zvolsky, Ana Rath

Summary: The study tested the use of a specific rare disease (RD) codification system in five European countries/regions and found that the ORPHAcodes were a versatile resource for coding RD. They were able to provide ease of use and comparability across different databases. The ORPHAcodes described disease entities more precisely than the corresponding ICD-10 codes in the majority of cases.

ORPHANET JOURNAL OF RARE DISEASES (2023)

No Data Available